Omega3 Research Info
Written Articles &
Studies on Omega-3 Fatty Acids
Helps Support A Healthy
Brain
Helps Support A
Healthy
Heart
Helps Support A
Healthy Immune System
Helps Maintain Cholesterol
Levels within The Normal Range
Helps Support Healthy Joint
Movement
Helps Support Healthy
Kidneys
Helps Support Balanced Mood and Sense
of Well Being
Helps Support
Strength and Stamina
Website Articles & Studies
on Omega-3 Fatty Acids
WebMD articles and studies about fish oil
A Brief History of
The Human Brain
Fish Oil
and Your Heart
Omega-3 vs.
Omega-6 Fatty Acids
Best Source for Fatty Acids
Have a Healthy
Heart
Healthy Aging
The Skinny on
Cholesterol
Helps Support A Healthy Brain
Burgress,
J. R., L. Stevens, and L. Peck. "Long-chain polyunsaturated fatty
acids in children with attention-deficit hyperactivity disorder."
Am J Clin Nutr 71:327S-330S (2000).
Connor, W. E., M.
Neuringer, and D. S. Lin. "Dietary effects on brain fatty acid
composition: The reversibility of n-3 fatty acids deficiency and
turnover of docosahexaenoic acid in the brain erythrocytes and
plasma of rhesus monkeys." J Lipid Res 31:237-247
(1990).
Connor, W. E., M. Neuringer, and S. Reisbick.
"Essential fatty acids: Importance of n-3 fatty acids in the retina
and brain." Ntr Rev 50:21-29 (1992).
Conquer, J. A.,
M. C. Tierney, J. Zecevic, W.J. Bettger, and R.H. Fisher. "Fatty
acid analysis of blood plasma of patients with Alzheimer's disease,
other types of dementia, and cognitive impairment." Lipids
35:1305-1312 (2000).
Fenton W. ., Dickerson F., Boronow J.,
Hibbeln J. R., Knable M. “A placebo-controlled trial of omega-3
fatty acid (ethyl eicosapentaenoic acid) supplementation for
residual symptoms and cognitive impairment in schizophrenia.” Am
J Psychiatry 158(12):2071-4 (2001).
Gamoh, S., M.
Hashimoto, K. Sugioka, S. Hossain, N. Hata, Y. Misawa, and S.
Masumura. "Chronic administration of docosahexaenoic acid improves
reference memory-related learning ability in young rats."
Neurosci 93:237-241 (1999).
Jones, C. R., T. Aria, and
S. I. Rapoport. "Evidence for the involvement of docosahexaenoic
acid in cholinergic simulated signal transduction at the synapse."
J Neurochem Res 22:663-670 (1997).
Katzman, R., and J.
E. Jackson. "Alzheimer disease: Basic and clinical advances." J
Am Geriatrics Soc 39:516-525 (1991).
Kodas E., Page G.,
Zimmer L., Vancassel S., Guilloteau D., Durand G., Chalon S.
"Neither the density nor function of striatal dopamine transporters
were influenced by chronic n-3 polyunsaturated fatty acid deficiency
in rodents.” Neurosci Lett 321(1-2):95-9 (2002).
Kyle,
D. J., E. Schaefer, G. Patton, and A. Beiser. "Low serum
docosahexaenoic acid is a significant risk factor for Alzheimer's
dementia." Lipids 34:S245 (1999).
Lauritzen,
I., N.
Blondeau, C. Heurteaux, C. Widmann, G. Romey, and M. Lazdunski.
"Polyunsaturated fatty acids are potent neuroprotectors." EMBO J
19:1784-1793 (2000).
Lauritzen, L., H. S. Hansen, M. H.
Jorgensen, and K. F. Michaelsen. "The essentiality of long-chain n-3
fatty acids in relation to development and function of the brain and
retina." Prog Lipid Res 40:1-94 (2001).
Marangell L B,
Martinez J M, Zboyan H A, Kertz B, Kim H F, Puryear L J. “A
double-blind, placebo-controlled study of the omega-3 fatty acid
docosahexaenoic acid in the treatment of major depression.”
Mood
Disorders
Center,
Department of Psychiatry, Baylor
College of
Medicine,
Houston,
TX,
USA.
Schiefermeier
M., Yavin E. “n-3 Deficient and docosahexaenoic acid-enriched diets
during critical periods of the developing prenatal rat brain.” J
Lipid Res 43(1):124-31 (2002).
Sonderberg, M., C. Edlund,
K. Kristensson, and G. Dallner. "Fatty acid composition of brain
phospholipids in aging and Alzheimer's disease." Lipids
26:421-423 (1991).
Stevens, L. J., and J. Burgess. "Omega-3
fatty acids in boys with behavior, learning, and health problems."
Physiol Behav 59:915-920 (1996).
Stevens, L. J., S. S.
Zentall, J. L. Deck, M. L. Abate, B. A. Watkins, S. A. Lipp, and J.
R. Burgess. "Essential fatty acid metabolism in boys with
attention-deficit hyperactivity disorder." Am J Clin Nutr
62:761-768 (1995).
Stordy, B. J. "Benefit of docosahexaenoic
acid supplements to dark adaption in dyslexics." Lancet
346:385 (1995).
Terano, T., S. Fujishiro, T. Ban, K.
Yamamoto, T. Tanaka, Y. Noguchi, Y. Tamura, K. Yazawa, and T.
Hirayama. "Docosahexaenoic acid supplementation improves moderately
severe dementia from thromboitc cerebrovascular diseases.
Lipids 34:S345-S346 (1999).
Voigt, R. G., A. M.
Llorente, C. L. Jensen, J. K. Fraley, M.C. Berretta, and W. C.
Heird. "A randomized, double-blind, placebo-controlled trial of
docosahexaenoic acid supplementation in children with
attention-deficit/hyperactivity disorder." J Pediatr
139:189-196 (2001).
Vance, H. E., R. B. Campenot, and D.
E. Vance. "The synthesis and transport of lipids for axonal growth
and nerve regeneration." Biochim Biophys Acta 1486:84-96
(2000).
Yeh, Y. Y., M. F. Gehman, and S. M. Yeh. "Maternal
dietary fish oil enriches docosahexaenoate levels in brain
subcellular fractions of offspring." J Neurosci Res
35:218-226 (1993).
Yehuda, S., S. Rabinovitz, R.L.
Carasso, and D.I. Mostofsky. "Essential fatty acid preparation
improves Alzheimer's patients' quality of life." Int J
Neurosci 87:141-149 (1996).
Willatts, P., J. S. Forsyth,
M. K. DiModugno, S. Varma, and M. Colvin. “Effect of long-chain
polyunsaturated fatty acids in infant formula on problem solving at
10 months of age.” Lancet 352:688-691 (1998).
Helps Support A Healthy
Heart
Albert, C.
M., C. H. Hennekens, C.I. O'Donnel, U. A. Ajani, V. J. Carey, and W.
C. Willett. "Fish consumption and risk of sudden cardiac death."
JAMA 279:23-28 (1998).
Angerer P., Kothny W., Stork
S., von Schacky C. “Effect of dietary supplementation with omega-3
fatty acids on progression of atherosclerosis in carotid arteries.”
Klinikum der Universitat Munchen, Institut und Poliklinik fur
Arbeits- und Umweltmedizin-Innenstadt, Ziemssenstrasse 1,
Germany.
Appel,
Lawrence J., et al. “Does supplementation of diet with "fish oil"
reduce blood pressure?” Archives of Internal Medicine
153:1429-38 (1993).
Christensen, J. H., M. S.
Christensen, J. Dyerberg, and E. B. Schmidt. "Heart rate variability
and fatty acid content of blood cell membranes: A dose-response
study with n-3 fatty acids." Am J Clin Nutr 70:331-337
(1999).
Christensen, Jeppe Hagstrup, et al. “Heart rate
variability and fatty acid content of blood cell membranes: a
dose-response study with n-3 fatty acids. “ American Journal of
Clinical Nutrition 70:331-37 (1999).
Christensen, Jeppe
Hagstrup, et al. “Effect of fish oil on heart rate variability in
survivors of myocardial infarction. “ British Medical Journal
312:677-78 (1996).
Christensen, Jeppe Hagstrup, et al. “Heart
rate variability and fatty acid content of blood cell membranes: a
dose-response study with n-3 fatty acids. “ American Journal of
Clinical Nutrition 70:331-37 (1999).
Dehmer, G. J., J. J.
Popma, E. K. van den Berg, E. J. Eichorn, J. B. Prewitt, W. B.
Campbell, L. Jennings, J. T. Willerson, and J. M. Schmitz.
"reduction in the rate of early restenosis after coronary
angioplasty by a diet supplemented with n-3 fatty acids." N Engl
J Med 319:733-740 (1998).
Engler M. M., Engler M. B.,
Pierson D. M., Molteni L. B., Molteni A. “Effects of docosahexaenoic
acid on vascular pathology and reactivity in hypertension.”
Laboratory of Cardiovascular Physiology, Department of Physiological
Nursing, University of California, San Francisco, California
94143-0610, USA.
Eritsland, J., H. Arnesen, K. Bronseth, N.
B. Fjeld, and M. Abdelnoor. "Effect of dietary supplementation with
n-3 fatty acids on coronary artery bypass graft patency." Am J
Cardio 77:31-36 (1996).
Eritsland, J., et al. "Long-term
effects of n-3 polyunsaturated fatty acids on haemostatic variables
and bleeding episodes in patients with coronary artery disease."
Blood Coagulation and Fibrinolysis 6:17-22
(1995).
Flaten, Hugo, et al. “Fish-oil concentrate: effects
of variables related to cardiovascular disease.“ American Journal
of Clinical Nutrition 52:300-06 (1990).
Geelen A.,
Brouwer I. A., Zock P. L., Kors J. A., Swenne C. A., Katan M. B.,
Schouten E. G. “(N-3) fatty acids do not affect electrocardiographic
characteristics of healthy men and women. J Nutr
132(10):3051-4 (2002).
GISSI-Prevenzione Investigators.
"Dietary supplementation with n-3 polyunsaturated fatty acids and
vitamin E after myocardial infarction: Results of the
GISSI-Prevenzione trial." Lancet 354:447-455
(1999).
Harris, W. S., and W. L. Isley. "Clinical trial
evidence for the cardioprotective effects of omega-3 fatty acids."
Curr Atheroscler Rep 3:174-197 (2001).
Leaf, A., G. E.
Billman, and H. Hallaq. "Prevention of ischemia-induced ventricular
fibrillation by omega-3 fatty acids." Proc Nat Acad Sci
USA
91:4427-4430 (1994).
Leaf, A., and J. X. Kang. "Dietary n-3
fatty acids in the prevention of lethal cardiac arrhythmias."
Curr Opin Lipidol 8:4-6 (1997).
Leaf, A., J. X. Kang,
Y F. Xiao, and G. E. Billman. "Dietary n-3 fatty acids in the
prevention of cardiac arrhythmias." Curr Opin Clin Nutr Metab
Care 1:225-228 (1998).
Marchioli, Roberto, et al.
“Efficacy of n-3 polyunsaturated fatty acids after myocardial
infarction: results of GISSI-Prevenzione trial. “ Lipids
36:S119-S126 (2001).
Marchioli, Roberto, et al. “Early
protection against sudden death by n-3 polyunsaturated fatty acids
after myocardial infarction: time-course analysis of the results of
GISSI-Prevenzione. “ Circulation 105:1897-1903
(2002).
Morris, Martha Clare, et al. “Does fish oil lower
blood pressure? A meta-analysis of controlled trials.“
Circulation 88(2):523-33 (1993).
Olszewski, A. J.
"Fish oil decreases homocysteine in hyperlipidemic men." Coronary
Artery Dis 4:53-60 (1993).
Radack, K. C. Deck, and G.
Huster. "Dietary supplementation with low-dose fish oils lowers
fibrinogen levels." Ann Intern Med 11:757-758
(1989).
Radack, Kenneth, et al. “The effects of low doses of
n-3 fatty acid supplementation on blood pressure in hypertensive
subjects. “ Archives of Internal Medicine 151:1173-80
(1991).
Rissanen, T. S. Voutilainen, K. Myyssonen, T.A.
Lakka, and J. T. Salonen. "Fish oil-derived fatty acids,
dodosahexaenoic acid, and docosapentaenoic acid, and the risk of
acute coronary events: The Kuopio ischaemic heart disease risk
factor study." Circulation 102:2677-2679
(2000).
Singh, Ram B., et al. Randomized, double-blind,
placebo-controlled trial of fish oil and mustard oil in patients
with suspected acute myocardial infarction: the Indian experiment of
infarct survival. Cardiovascular Drugs and Therapy 11:485-91
(1997).
Von Schacky, C., P. Angerer, W. Kothny, K. Theisen,
and H. Mudra. "The effect of dietary omega-3 fatty acids on coronary
atherosclerosis: A randomized, double-blind placebo-controlled
trial." Ann Intern Med 130:554-562 (1999).
Von
Schacky, Clemens. n-3 fatty acids and the prevention of coronary
atherosclerosis. American Journal of Clinical Nutrition
71(suppl):S224-27S (2000).
Helps Support A Healthy Immune
System
Anti,
Marcello, et al. “Effects of different doses of fish oil on rectal
cell proliferation in patients with sporadic colonic adenomas.”
Gastroenterology 107:1709-1718 (1994).
Barber, M. D.,
J. A. Ross, A. C. Voss, M. J. Tisdale, and K. C. Fearon. "The effect
of an oral nutritional supplement enriched with fish oil on
weight-loss in patients with pancreatic cancer.” Br J Cancer
81:80-86 (1999).
Barber, M. D., D. C. McMillan, T.
Preston, J. A. Ross, and D. C. Fearon. "Metabolic response to
feeding in weight-losing pancreatic cancer patients and its
modulation by a fish-oil-enriched nutritional supplement." Clin
Sci 98:389-399 (2000).
Barber, M. D., and K. C. H.
Fearon. "Tolerance and incorporation of a high-dose eicosapentaenoic
acid diester emulsion by patients with pancreatic cancer cachexia."
Lipids 36:347-351 (2001).l
Bechoua, S., M. Dubois, G.
Nemoz, P. Chapy, E. Vericel, M. Lagarde, and A. F. Prigent. "Very
low dietary intake of n-3 fatty acids affects the immune function of
healthy elderly people." Lipids 34:S143
(1999).
Endres, S., R. Ghorbani, V. E. Kelley, K. Georgilis,
G. Lonnemann, J. W. van der Meer, J. G. Cannon, T. S. Rogers, M. S.
Klempner, P. C. Weber, et al. "The effect of dietary supplementation
with n-3 polyunsaturated fatty acids on the synthesis of
interleukin-1 and tumor necrosis factor by mononuclear cells." N
Engl J Med 320:265-271 (1989).
Ergas D., Eilat E.,
Mendlovic S., Sthoeger Z. M. “n-3 fatty acids and the immune system
in autoimmunity.” Isr Med Assoc J 4(1):34-8
(2002).
Fernandez, E., L. Chatenoud, C. La Vecchia, E. Negri,
S. Franceschi. "Fish consumption and cancer risk." Am J Clin
Nutr 70:85-90 (1999).
Gogos, C. A., P. Ginopoulos, B.
Salsa, E. Apostolidou, N. C. Zoumbos, and F. Kalfarentzos. "Dietary
omega-3 polyunsaturated fatty acids plus vitamin E restore
immunodeficiency and prolong survival for severely ill patients with
generalized malignancy: A randomized control trial." Cancer
82:395-402 (1998).
Lee, T. H., R. L. Hoover, J. D.
Williams, R. I. Sperling, J. Ravalese, B. W. Spur, D. R. Robinson,
E. J. Corey, R. A. Lewis, and K. P Austen. "Effect of dietary
enrichment with eicosapentaenoic acid and docosahexaenoic acid on in
vitro neurophil and monocyte leukotriene generation and neurophil
function." N Engl J Med 312:1217-1224
(1985).
Robinson, D. R. "Alleviation of autoimmune disease by
dietary lipids containing omega-3 fatty acids." Rheum Dis Clin
North Am 17:213-222 (1991).
Robinson, D. R., L. L. Xu, S.
Tateno, M. Guo, and R. E. Colvin. "Suppression of autoimmune disease
by dietary n-3 fatty acids." J Lipid Res 34:1435-1444
(1993).
Sperling, R. I. "The effects of dietary n-3
polyunsaturated fatty acids on neutrophils." Proc Nutr Soc
57:527-534 (1998).
Terada S., Takizawa M., Yamamoto S.,
Ezaki O., Itakura H., Akagawa K. S. Suppressive mechanisms of EPA on
human T cell proliferation.” Microbiol Immunol 45(6):473-81
(2001).
Wigmore, S. J. M. D. Barber, J. A. Ross, M. J.
Tisdale, and K. C. Fearon. "Effect of oral eicosapentaenoic acid on
weight loss in patients with pancreatic cancer." Nutr Cancer
36:177-814 (2000).
Helps Maintain Cholesterol Levels That
Are Already Within The Normal Range
Caron M.
F., White C. M. “Evaluation of the antihyperlipidemic properties of
dietary supplements.” Pharmacotherapy 21(4):481-7
(2001)..
Haglund, O., R. Wallin, R. Luostarinen, and T.
Saldeen. "Effects of a new fluid fish oil concentration on
triglycerides, cholesterol, fibrinogen, and blood pressure." J
Intern Med 227:347-353 (1990).
Harris, W. S. "N-3 fatty
acids and serum lipoproteins: Human studies." Am J Clin Nutr
65:1645S-1654S (1997).
Harris, W. S. "N-3 Fatty acids and
human lioprotein metabolism: An update." Lipids 34:S257-S258
(1999).
Harris, W.S., H. N. Ginsberg, N. Arunakul, N. S.
Shachter, S. L. Windsor, M. Adams, L. Berlund, and K. Osmundsen.
"Safety and efficacy of Omacor in severe hypertriglyceridemia." J
Cardiovasc Risk 4:385-392 (1997).
Lichtenstein A. H ,
Ausman L. M., Jalbert S. M., Vilella-Bach M., Jauhiainen M.,
McGladdery S., Erkkila A. T., Ehnholm C., Frohlich J., Schaefer E.
J. “Efficacy of a Therapeutic Lifestyle Change/Step 2 diet in
moderately hypercholesterolemic middle-aged and elderly female and
male subjects.” J Lipid Res 43(2):264-73
(2002).
Nilsen D. W., Albrektsen G., Landmark K., Moen S.,
Aarsland T., Woie L. “Effects of a high-dose concentrate of n-3
fatty acids or corn oil introduced early after an acute myocardial
infarction on serum triacylglycerol and HDL cholesterol.” Am J
Clin Nutr 74(1):50-6 (2001).
Puiggros C., Chacon P.,
Armadans L. I., Clapes J., Planas M. Effects of oleic-rich and
omega-3-rich diets on serum lipid pattern and lipid oxidation in
mildly hypercholesterolemic patients. Clin Nutr 21(1):79-87
(2002).
Stark, K. D., E. J. Park, V. A. Maines, and B. J.
Holub. "Effect of a fish-oil concentrate on serum lipids in
postmenopausal women receiving and not receiving hormone replacement
therapy in a placebo-controlled, double-blind trial." Am J Clin
Nutr 72:389-394 (2000).
Villa B., Calabresi L., Chiesa
G., Rise P., Galli C., Sirtori C. R. “Omega-3 fatty acid ethyl
esters increase heart rate variability in patients with coronary
disease. “ Department of Pharmacological Sciences, Centre E. Grossi
Paoletti,
University of
Milan, Via
Balzaretti 9, 20133
Milan,
Italy.
Helps Support Healthy Joint
Movement
Ariza-Ariza,
R., M. Peralta-Mestanza, and M. H. Cardiel. "Omega-3 fatty acids in
rheumatoid arthritis: An overview." Sem Arthr Rheum
27:366-370 (1998).
Cleland, L. G., J. K. French, W. H. Betts,
G. A. Murphy, and M. J. Elliott. "Clinical and biochemical effects
of dietary fish oil supplements in rheumatoid arthritis." J
Rheumatol 15:1471-1475 (1988).
Curtis C. L., Rees S. G.,
Cramp J., Flannery C. R., Hughes C. E., Little C. B., Williams R.,
Wilson C., Dent C. M., Harwood J. L., Caterson B. “Effects of n-3
fatty acids on cartilage metabolism.” Proc Nutr Soc
61(3):381-9 (2002).
Espersen, G. T., N. Grunnet, H. H.
Lervang, G. L. Nielsen, B. S. Thomsen, K. L. Faarvang, J. Dyerberg,
and E. Ernst. "Decreased interleukin-1 beta levels in plasma from
rheumatoid arthritis patients after dietary supplementation with n-3
polyunsaturated fatty acids." Clin Rheumatol 11:393-395
(1992).
Fortin, Paul R., et al. “Validation of a
meta-analysis: the effects of fish oil in rheumatoid arthritis. “
Journal of Clinical Epidemiology 48:1379-90
(1995).
Geusens, P., C. Wouters, J. Nijs, Y. Jiang, and J.
Dequeker. "Long-term effect of omega-3 fatty acid supplementation in
active rheumatoid arthritis: A 12-month, double-blind, controlled
study." Arthritis Rheum 37:824-829 (1994).
Judex S.,
Wohl G. R., Wolff R. B., Leng W., Gillis A. M., Zernicke R. F.
“Dietary fish oil supplementation adversely affects cortical bone
morphology and biomechanics in growing rabbits.” Calcif Tissue
Int 66(6):443-8 (2000).
Kremer, J. M., D. A. Lawrence, W.
Jubiz, R. DiGiacomo, R. Rynes, L. F. Bartholomew, and M. Sherman.
"Dietary fish oil and olive oil supplementation in patients with
rheumatoid arthritis: Clinical and immunologic effects."
Arthritis Rheum 33:810-820 (1990).
Kremer, J. M., D.
A. Lawrence, G. F. Petrillo, L. L. Litts, P. M. Mullaly, R. J.
Rynes, R. P. Stocker, N. Parhami, N. S. Greenstein, and B. R. Fuchs.
"Effects of high-dose fish oil on rheumatoid arthritis after
stopping nonsteroidal anti-inflammatory drugs: Clinical and immune
correslates." Arthritis Rheum 38:1107-1114
(1995).
Kremer, J. M. "N-3 Fatty acid supplements in
rheumatoid arthritis." Am J Clin Nutr 71:349S-351S
(2000).
Kremer, Joel M., et al. “Fish-oil fatty acid
supplementation in active rheumatoid arthritis: A double-blinded,
controlled, crossover study. “ Annals of Internal Medicine
106:497-503 (1987).
Terano, T. "Effect of omega-3
polyunsaturated fatty acid ingestion on bone metabolsim and
osteoporosis." World Rev Nutr Diet 88:141-=147
(2001).
Volker, Dianne, et al. “Efficacy of fish oil
concentrate in the treatment of rheumatoid arthritis. “ Journal
of Rheumatology 27:2343-46 (2000).
Helps Support Healthy
Kidneys
Brown, S.
A., C. A. Brown, W. A. Crowell, J. A. Barsanti, T. Allen, C. Cowell,
and D. R. Finco. "Beneficial effects of chronic administration of
dietary omega-3 polyunsaturated fatty acids in dogs with renal
insufficiency." J Clin Lab Med 131:447-455
(1998).
Brown, S. A., C. A. Brown, W. A. Crowell, J. A.
Barsanti, C-W. Kang, T. Allen, C. Cowell, and D. R. Finco. "Effects
of dietary polyunsaturated fatty acids supplementation in early
renal insufficiency in dogs." J Lab Clin Med 135:275-286
(2000).
Cappelli P., Di Liberato L., Stuard S., Ballone E.,
Albertazzi A. “N-3 polyunsaturated fatty acid supplementation in
chronic progressive renal disease.” J Nephrol 10(3):157-62
(1997).
Clark, W. F., A Parbtani, C. D. Naylor, C. M.
Levinton, N. Muirhead, E. Spanner, M. W. Huff, D. J. Philbrick, and
B. J. Holub. "Fish oil in lupus nephritis: Clinical findings and
methodological implications." Kidney Int 44:75-86
(1993).
Donadio, J. V., E. J. Bergstralh, K. P. Offord, D. C.
Spencer, and D. E. Holley. "A controlled trial of fish oil in IgA
nephropathy." N Engl J Med 331:1194-1199
(1994).
Donadio, J. V., J. P. Grande, E. J. Bergstralh, R. A.
Dart, T. S. Larson, and D. C. Spencer. "The long-term outcome of
patients with IgA nephropathy treated with fish oil in a controlled
trial." J Am Soc Nephrol 10:1772-1777 (1999).
Lenin
M., Thiagarajan A., Nagaraj M., Varalakshmi P. “Attenuation of
oxalate-induced nephrotoxicity by eicosapentaenoate-lipoate (EPA-LA)
derivative in experimental rat model.” Department of Medical
Biochemistry,
University
of Madras,
India.
Pettersson
E. E., Rekola S., Berglund L., Sundqvist K. G., Angelin B.,
Diczfalusy U., Bjorkhem I., Bergstrom J. “Treatment of IgA
nephropathy with omega-3-polyunsaturated fatty acids: a prospective,
double-blind, randomized study.” Clin Nephrol 41(4):183-90
(1994).
Prickett,
J. D., D. R. Robinson, and A. D. Steinberg. "Dietary enrichment with
polyunsaturated acid eicosapentaenoic acid prevents proteinuria and
prolongs survival in NZBxNZW F1 mice." J Clin Invest
68:556-559 (1981).
Sulikowska B., Manitius J., Nieweglowski
T., Szydlowska-lysiak W., Rutkowski B. “The effect of therapy with
small doses of mega-3 polyunsaturated fatty acid on renal reserve
and metabolic disturbances in patients with primary IGA
glomerulopathy.” Pol Arch Med Wewn 108(2):753-60 (2002).
Helps Support Balanced Mood and Sense of Well
Being
Adams.
P., S. Lawson, A. Sanigorski, and A.J. Sinclair. "Arachidonic acid
to eicosapentaenoic acid ratio in blood correlates positively with
clinical symptoms of depression." Lipids 31:S157-S161
(1996).
Burgress, J. R., L. Stevens, and L. Peck. "Long-chain
polyunsaturated fatty acids in children with attention-deficit
hyperactivity disorder." Am J Clin Nutr 71:327S-330S
(2000).
Hamazaki, T., S. Sawazaki, M. Itomura, E. Asaoka, Y.
Nagao, N. Nishimura, K. Yazawa, T. Kuwamori, and M. Kobayashi. "The
effect of docosahexaenoic acid on aggression in young adults." J
Clin Invest 97:1129-1134 (1996).
Hamazaki, T., S.
Sawazaki, M. Itomura, Y. Nagao, A. Thienprasert, T. Nagasawa, and S.
Watanabe. "Effect of docosahexaenoic acid on hostility." World
Rev Nutr Diet 88:47-52 (2001).
Hamazaki, T., S. Sawazaki,
T. Nagasawa, Y. Nagao, Y Kanagawa, and K. Yazawa. "Administration of
docosahexaenoic acid influences behavior and plasma catecholamine
levels at time of psychological stress." Lipids 34:S33-S37
(1999).
Hamazaki, T., M. Itomura, S. Sawazaki, and Y. Nagao.
"Anti-stress effects of D. H. A." Biofactors 13:41-45
(2000).
Hamazak T., Thienprasert A., Kheovichai K.,
Samuhaseneetoo S., Nagasawa T., Watanabe S. “The effect of
docosahexaenoic acid on aggression in elderly Thai subjects--a
placebo-controlled double-blind study.” Nutr Neurosc
5(1):37-41 (2002).
Maes, M. "Fatty acid composition in major
depression: Decreased n-3 fractions in cholesterol esters and
increased C20:46/C20:5n3 ratio in cholester ester and phosopholipds.
J Affect Dis 38:35-46 (1996).
Maes, M., A Christophe,
J. Delanghe, C. Altamura, H. Neels, and H.Y. Meltzer. "Lowered
omega-3 polyunsaturated fatty acids in serum phospholipids and
cholesterol esters of depressed patients." Psychiatry Res
85:275-291 (1999).
Mills, D. E., K. M. Prkochin, K. A.
Harvey, and R. P. Ward. "Dietary fatty acid supplementation alters
stress reactvity and performance in man." J Human
Hypertension 3:111-116 (1989).
Peet, M., J. Brind, C. N.
Ramchand, S. Shah, and G. K. Vankar. "Two double-blind
placebo-controlled pilot studies of eicosapentaenoic acid in the
treatment of schizophrenia." Schizophr Res 49:243-251
(2001).
Richardson, A.J., et al. “Red cell and plasma fatty
acid changes accompanying symptom remission in a patient with
schizophrenia treated with eicosapentaenoic acid. “ European
Neuropsychopharmacology 10 :189-93 (2000).
Stoll, Andrew
L., et al. “Omega 3 fatty acids in bipolar disorder.” Archives of
General Psychiatry 56:407-12 (1999).
Stoll, A. L., E.
Severus, M. P. Freeman, S. Reuter, H. A. Zhoyan, E. Diamond, K. K.
Cress, and L. B. Marangell. "Omega-3 fatty acids in bipolar
depression: A preliminary double-blind placebo-controlled trial."
Arch Gen Psychiatry 56:407-412 (1999).
Helps Support Strength and
Stamina
Bruckner,
G., P. Webb, L. Greenwell, C. Chow, and D. Richardson. "Fish oil
increases peripheral capillary blood cell velocity in humans."
Atherosclerosis 66:237-245 (1987).
Muoio, D. M., J. J.
Leddy, P. J. Horvath, A. B. Awad, and D. R. Pendergast. "Effect of
dietary fat on metabolic adjustments to maximal VO2 and endurance in
runner." Med Sci Sports Exerc 26:81-88
(1994).
Pendergast, D. R., P. J. Horvath, J. J. Leddy, and J.
T. Venkatraman. "The role of dietary fat in performance, metabolism,
and health." Am J Sports Med 24:S53-S58
(1996).
Raastad T., Hostmark A. T., Stromme S. B. “Omega-3
fatty acid supplementation does not improve maximal aerobic power,
anaerobic threshold and running performance in well-trained soccer
players.” Scand J Med Sci Sports 7(1):25-31
(1997).
Salachas, Anastasios, et al. “Effects of low-dose
fish oil concentrate on angina, exercise tolerance time, serum
triglycerides, and platelet function. “ Angiology 45:1023-31
(1994)
Voigt,
R. G., A. M. Llorente, C. L. Jensen, J. K. Fraley, M.C. Berretta,
and W. C. Heird. "A randomized, double-blind, placebo-controlled
trial of docosahexaenoic acid supplementation in children with
attention-deficit/hyperactivity disorder." J Pediatr
139:189-196 (2001).
Yehuda, S., S. Rabinovitz, R. L.
Carasso, and
D.
I.
Mostofsky. "Essential Fatty acid preparation improves Alzheimer's
patients' quality of life." Int J Neurosci 87:141-149 (1996).
|
